Katopodis, P.; Chudasama, D.; Wander, G.; Sales, L.; Kumar, J.; Pandhal, M.; Anikin, V.; Chatterjee, J.; Hall, M.; Karteris, E.
Kinase Inhibitors and Ovarian Cancer. Cancers 2019, 11, 1357.
https://doi.org/10.3390/cancers11091357
AMA Style
Katopodis P, Chudasama D, Wander G, Sales L, Kumar J, Pandhal M, Anikin V, Chatterjee J, Hall M, Karteris E.
Kinase Inhibitors and Ovarian Cancer. Cancers. 2019; 11(9):1357.
https://doi.org/10.3390/cancers11091357
Chicago/Turabian Style
Katopodis, Periklis, Dimple Chudasama, Gurleen Wander, Louise Sales, Juhi Kumar, Manreen Pandhal, Vladimir Anikin, Jayanta Chatterjee, Marcia Hall, and Emmanouil Karteris.
2019. "Kinase Inhibitors and Ovarian Cancer" Cancers 11, no. 9: 1357.
https://doi.org/10.3390/cancers11091357
APA Style
Katopodis, P., Chudasama, D., Wander, G., Sales, L., Kumar, J., Pandhal, M., Anikin, V., Chatterjee, J., Hall, M., & Karteris, E.
(2019). Kinase Inhibitors and Ovarian Cancer. Cancers, 11(9), 1357.
https://doi.org/10.3390/cancers11091357